S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.

MLA

Colón, Krystal, et al. “S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 80, no. 2, Feb. 2019, pp. 234–41. EBSCOhost, https://doi.org/10.1097/QAI.0000000000001911.

APA

Colón, K., Speicher, D. W., Smith, P., Taylor, M., Metzger, D. S., Montaner, L. J., & Tomescu, C. (2019). S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk. Journal of Acquired Immune Deficiency Syndromes (1999), 80(2), 234–241. https://doi.org/10.1097/QAI.0000000000001911

Chicago

Colón, Krystal, David W Speicher, Peter Smith, Mack Taylor, David S Metzger, Luis J Montaner, and Costin Tomescu. 2019. “S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.” Journal of Acquired Immune Deficiency Syndromes (1999) 80 (2): 234–41. doi:10.1097/QAI.0000000000001911.